As part of its education program titled, Returning to Practice in the Post-COVID-19 Era: Resources for Treating CLL, the Association of Cancer Care Centers (ACCC) is seeking an oncologist to participate in a 30-minute key informant interview to share their experience with managing patients with CLL in the COVID-19/post-COVID-19 era. ACCC will highlight findings from the interviews in a whitepaper on treating CLL in the pandemic era. The interviewee will receive a $100 honorarium.
If interested, please contact Program Manager, Limaya Atembina at latembina@accc-cancer.org. You may also fill out the Volunteer Registry Form by clicking "Apply Now" below and indicating "CLL Interview" when asked if a specific opportunity interests you.
Apply now

In a recent article from Oncology Issues, authors conducted a systematic literature review and found that two main drivers of care disparities exist for transgender and nonbinary individuals with cancer: rigid binary gender frameworks and gaps in mental health care.

2026 ACCC Innovator Award Winner St. Luke's Cancer Institute noticed a significant administrative burden being placed on providers to review medical necessity validation for complex oncology therapies. To address the resulting rise in peer-to-peer requirements, delays in care, and pre-service denials, the team designed and implemented a new Clinical Documentation Integrity Registered Nurse role.

ACCC launched its Precision Medicine Stewardship Program to highlight institutions that have successfully built the infrastructure, workflows, and leadership models needed to deliver precision medicine at scale. TriHealth Cancer and Blood Institute in Cincinnati, Ohio, offers a compelling example of what it takes to move from aspiration to execution.

Although patients with relapsed or refractory multiple myeloma now have more treatment options than ever, their journeys are often complex. As clinicians consider when to introduce newer therapies such as bispecific antibodies, they must account for prior treatments, treatment-related toxicities, and comorbidities that may impact treatment decisions.
